Metastasis from Thyroid Cancer

Rodrigo Arrangoiz MS, MD, FACS, FSSO
  • Papillary and Follicular Carcinoma: Surgical and Radioiodine Treatment of Distant Metastasis.
  • Distant metastases occur in 2% to 23% of patients with differentiated thyroid cancer, and approximately 50% will die of disease within 5 years of diagnosis.
  • Pulmonary metastases are the most common, followed by bone metastases.
  • Patients with distant metastases, in general, have a poorer prognosis, but when metastases are small and radioiodine-avid, complete remission with 131I ablation is still possible in about 35% of the cases.
  • Children and young adults less than 45 years with pulmonary micrometastases identified by 131I scanning, but not seen on plain radiographs, have the best prognosis.
  • Distant micrometastases are best detected after total thyroidectomy and appropriate lymph node dissection of involved compartments.
  • Older patients with multiple extrapulmonary metastases that are not radioiodine avid have the worst prognosis.
  • Serum Tg levels and radioiodine scanning are the most sensitive indicators of persistent disease, although PET / CT may be useful in patients with negative radioiodine scans.
  • Surgical resection of metastases and adjunct interventions such as arterial embolization, ethanol or radiofrequency ablation, and external radiation may be beneficial in patients with isolated metastases or may be used to minimize morbidity and improve quality of life.

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

1 thought on “Metastasis from Thyroid Cancer”

  1. I am one of Rodrigo ARRANGOIZ surgical oncologist patients, at the beginning of 2015 He made surgeries of breast, thyroid. and parathyroids.
    Very interested in the articles related to his oncology research and experience.
    He found out at the very right time the burst, thyroid and parathyroid Cancer I was developing.
    He proceeded with oncological surgeries, giving me back health.
    It is my decision to share my testimony. Thanks Oncologist Surgeon
    Rodrigo ARRANGOIZ
    Teresa Schriever

    Liked by 1 person

    Reply

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s